4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data
- 31 March 1983
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 10 (1) , 1-22
- https://doi.org/10.1016/s0305-7372(83)80029-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Phase II clinical trial of cis dichlorodiammine platinum (Cis DDP) in metastatic brain tumorsZeitschrift für Krebsforschung und Klinische Onkologie, 1982
- Determination of 4′-epidoxorubicin and its 13-dihydro derivative in human plasma by high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Carcinoma of renal parenchyma, renal pelvis and ureter—radiological diagnosis and treatment planningCancer Treatment Reviews, 1980
- Studies on the mode of interaction of 4'-epi-adriamycin and 4-demethoxy-daunomycin with DNABiochemical Pharmacology, 1978
- Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moietyChemico-Biological Interactions, 1977
- Dose response evaluation of adriamycin in human neoplasiaCancer, 1977
- Combination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group studyCancer, 1976
- Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinoneJournal of Medicinal Chemistry, 1975
- Phase II evaluation of adriamycin in human neoplasiaCancer, 1973
- Bedside technics for the evaluation of ventricular function in manThe American Journal of Cardiology, 1969